California Texas Louisiana New York Iowa Oregon Nebraska Missouri Washington Ohio Colorado Tennessee Pennsylvania Florida Alabama North Carolina South Carolina Arkansas Kentucky Oklahoma Michigan Indiana Illinois Virginia Massachusetts Maryland Nevada Minnesota Arizona Alaska New Mexico Mississippi Wisconsin Kansas Georgia Maine Montana West Virginia Vermont North Dakota Utah Wyoming South Dakota Idaho RH

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2568 blog entries.

Virginia

The Commonwealth is poised to strengthen PBM regulation in the commercial market with the passage of SB 669, which has been sent to Gov. Abigail Spanberger (D) for approval. The bill mandates pass-through pricing for PBMs, requires insurers to offer at least one prescription plan with a fee-only compensation structure if requested, bans retroactive payment cuts and protects pharmacies from PBM retaliation for filing complaints. Additionally, the Administration intends to move forward with the process to implement a Single PBM model in Medicaid Managed Care, supported by the inclusion of startup funding for the RFP process in the current budget proposal, which is still being negotiated.  

Also in Virginia, the Board of Pharmacy posted the March 17 agenda packet. Please note that it includes the 2025 Pharmacist and Pharmacy Technician Workforce Survey Report(s). 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-03-13T11:05:47-04:00March 13, 2026|Virginia|

Washington

SSB 5934, the standard of care bill that could expand pharmacists’ practice authority by allowing them to independently prescribe and diagnose within their scope of practice based on education and experience, passed the Senate but died in the House Health Care and Wellness Committee. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-03-13T11:05:13-04:00March 13, 2026|Washington|

Wyoming

The Department of Health (WDH) officials stated concerned about the ongoing, active spread of pertussis (whooping cough) across the state. Kaylyn Friesen, vaccine-preventable disease epidemiologist with WDH, said there have been 26 confirmed pertussis cases in the state so far this year.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-03-13T11:04:39-04:00March 13, 2026|Wyoming|

Colorado

The House Health and Human Services Committee held a hearing this week on SB 26-032, legislation that passed the Senate earlier this month. The bill strengthens access to pharmacy vaccine services and codifies Board of Pharmacy rules regarding pharmacists’ authority to prescribe and administer vaccines. NACDS submitted a statement supporting the bill. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-27T09:46:09-05:00February 27, 2026|Colorado|

Illinois

Effective December 31, 2025, generic Novolog (insulin aspart) and generic Tresiba (insulin degludec) vials and pens were discontinued by the manufacturer. In response, the Department of Healthcare and Family Services (HFS) has moved the brand name Humalog (insulin lispro) products to preferred status and will continue to maintain the generic insulin lispro and brand name Lantus (insulin glargine) products as preferred on the Preferred Drug List (PDL).  

To ensure that interruption in treatment is avoided, pharmacies are encouraged to contact the patient's doctor to request a change to a preferred rapid acting insulin agent. Pharmacies may continue to dispense generic insulin until stock is exhausted.  

Also in Illinois, effective April 15, Healthcare and Family Services (HFS) will once again designate Contour Plus Blue blood glucose meters and test strips as preferred agents on the Preferred Drug List (PDL). In the Provider Notice issued 10/24/2025, prior authorization was temporarily removed for the non-preferred brands, OneTouch, Accu-Chek and FreeStyle blood glucose meters and blood glucose test strips due to shortages of Contour Plus Blue products. Healthcare and Family Services (HFS) has been in communication with Ascensia Diabetes Care, the manufacturer of Contour Plus Blue products, which has confirmed that the out-of-stock issues experienced last year have been rectified.  

If Illinois Medicaid customers received OneTouch, Accu-Chek or FreeStyle blood glucose meters and blood glucose strips since October 24, 2025, a new prescription is required to change over to the Contour Plus Blue products. Prior authorization is necessary for OneTouch, Accu-Chek or FreeStyle products.  

This change will apply to Fee-For-Service (FFS) and Managed Care Organizations (MCOs).  

Questions regarding this notice may be directed to the Bureau of Professional and Ancillary Services at 877-782-5565 or the applicable MCO.  

Also in Illinois, the Illinois Retail Merchants Association (IRMA) announced the availability of an online application for the Pharmacy Assistance Program. Supported by a grant from the Department of Commerce and Economic Opportunity, IRMA will provide direct payments to qualifying pharmacies in the state to increase the availability of pharmacy services in the state's underserved communities. Details about the application and qualifications can be found by clicking the button below. Pharmacies are encouraged to apply soon as the application period closes at midnight on March 31. For questions regarding the program or the application, please email info@irma.org.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-02-27T09:45:40-05:00February 27, 2026|Uncategorized|

Kansas

The Senate approved, by a vote of 32-8, legislation that NACDS supports that would regulate PBMs. SB 360, the Kansas Consumer Prescription Protection and Accountability Act, defines auditing procedures, outlines reporting requirements and enhances enforcement authority by allowing for compliance and financial examinations. The bill was sent to the House for further consideration. 

Also in Kansas, the House of Representatives approved by a vote of 95-27, HB 2676, legislation expanding the scope of practice for pharmacists. The bill allows for the initiation of therapy, including medication and durable medical equipment, under certain circumstances and requires pharmacists who independently initiate therapy to maintain professional liability insurance. The bill has been referred to the Senate for further consideration. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-27T09:44:46-05:00February 27, 2026|Kansas|

Nevada

The Board of Pharmacy posted the agenda for a two-day meeting in Las Vegas on March 4 and 5.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-02-27T09:43:52-05:00February 27, 2026|Nevada|

New York

The State Department of Health’s NYRx Education & Outreach (E&O) team held a webinar on February 25 focusing on different areas of the Medicaid Pharmacy Program. The customized webinar was directed toward pharmacies, pharmacists and pharmacy staff who care for the state’s Medicaid members and covered several topics, including pharmacy enrollment, coordination of benefits and billing guidance. The session was held as part of a series, which will extend through March, occurring Wednesdays, from 12:00 pm – 1:00 pm ET. Registration is required to join. To register, select a date and click the link to register.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2026-02-27T09:43:12-05:00February 27, 2026|New York|
Go to Top